Tag Archives: vaccine development

European Vaccine Initiative enters two new malaria vaccines into clinical development

Malaria

Tweet The European Vaccine Initiative (EVI) said on Tuesday that two of its 16 projects to develop a malaria vaccine received ethical and regulatory approval to begin clinical stages of research. The two candidates, P27A and AMA1-DiCo, are supported technically … Read More »

Filed in Vaccine Development | Tagged , | Leave a comment

Pitt CVR and Sanofi Pasteur partner to study dengue vaccine candidate

Dengue fever

Tweet The University of Pittsburgh Center for Vaccine Research (Pitt CVR) announced on Tuesday that it will partner with Sanofi Pasteur to study the effectiveness of its newly introduced dengue vaccine. Pitt CVR will develop a new test to assess … Read More »

Filed in Vaccine Development | Tagged , | 1 Comment

Meningitis Research Foundations begins new study and model

Meningitis Research Foundation

TweetThe Meningitis Research Foundation said on Wednesday that it will begin research on how to assess potential Group B Streptococcal vaccines against meningitis and the impact of introducing vaccines to pregnant women. The study will be led by Caroline Trotter … Read More »

Filed in Vaccine Development | Tagged , , | Leave a comment

VaxInnate opens enrollment in Phase 1 clinical trial for seasonal influenza vaccine

Vaxinnate Signature

TweetThe VaxInnate Corporation announced that it has initiated enrollment in a Phase 1 clinical trial to observe the efficacy of its VAX2012Q, a recombinant quadrivalent vaccine against seasonal influenza infection. The Phase 1 clinical trial is a dose escalation study … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Scientists discover potent antibody against HIV infection

HIV

Tweet University of Granada scientists recently discovered a novel allosteric interaction between a part of the sheath of the HIV virus and antibody 2F5, which may become the foundation for a series of vaccines against HIV. The 2F5 antibody is … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Tuberculosis vaccine Phase II trial begins in South Africa

Tuberculosis

Tweet Statens Serum Institut and Aeras said on Tuesday that Phase II of the first randomized, controlled tuberculosis vaccine trial to study the prevention of Mycobacterium tuberculosis has begun. The vaccine, H4+IC21, will test the safety, immunogenicity and its ability … Read More »

Filed in Vaccine Development | Tagged , | 1 Comment

Seattle BioMed receives $9.8 million grant for HIV vaccine

Seattle BioMed

TweetSeattle BioMed, an independent, non-profit organization, announced on Tuesday that it received a $9.8 million grant from the National Institutes of Health to develop an HIV vaccine. The seven-year, Integrated Preclinical/Clinical AIDS Vaccine Development grant from the National Institute of … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

Integration of clinical and social science needed to advance HIV vaccines

HIV

Tweet Canadian HIV Vaccine Initiative researcher Peter Newman said on Friday that clinical and social sciences need to be integrated in order for HIV vaccine clinical trials to advance. Newman said testing vaccines ultimately involve human clinical trials, and research … Read More »

Filed in Vaccine Development | Tagged , | Comments Off

ABL picked by Profectus to evaluate HIV vaccine candidate

PaxVax appoints three new senior leaders

Study gives hope for novel, effective HIV vaccine

TNO Triskelion introduces new BSL-3 laboratory

Researchers find new target for dengue virus vaccine

BARDA extends contract with Novavax for pandemic vaccines

Sinovac’s EV71 vaccine effective against HFMD

Research shows self-administered flu vaccine may be feasible

Novartis’ Meningococcal B vaccine Bexsero approved for use in Canada

BiondVax meets with BARDA about universal flu vaccine

Pfizer announces successful CAPiTA trial of Prevenar 13

New discovery increases efficacy of mouse model in RASV clinical testing

Study to examine pros and cons of meningitis vaccine in the U.K.

Meningitis vaccine could reach remote African areas

Researchers develop method to deliver vaccines directly to lymph nodes

Scientists discover novel way to develop malaria vaccines

Daiichi Sankyo, UMN Pharma to collaborate on norovirus vaccine research

Meningitis vaccine MenAfriVac safe outside of cold chain

Dynavax withdraws marketing application for hepatitis B vaccine

BiondVax obtains flu vaccine patent approval in Hong Kong, U.S.

New technology may prevent Lyme disease transmission

Researchers discover how Dengue and WNV replicate

IAVI praises TSRI for new approach to vaccine design

Scripps announces novel vaccine development method against RSV